Sherif Algendy, MD
Pain Medicine · West Bridgewater, MANPI 1245293349
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.5%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Spinal Simplicity, LLC at 44.7% of the total. Reporting peaked in 2022 at $1,919 and has fallen 60.0% since, to $767 in 2025.
Across 144 payments — averaging $46.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Spinal Simplicity, LLC$3K
- Boston Scientific$3K
- Hydrocision, Inc.$500
- Abbott$107
- Amgen$99
- SPR Therapeutics, Inc$87
- plus $75 from 1 others
What the payments were for
- Consulting fees$5008%
- Travel & lodging$2,40036%
- Food & beverage$3,76256%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Spinal Simplicity, LLC | 28 | $2,977 |
| Boston Scientific | 108 | $2,816 |
| Hydrocision, Inc. | 1 | $500 |
| Abbott | 3 | $107 |
| Amgen | 1 | $99 |
| SPR Therapeutics, Inc | 1 | $87 |
| Si-bone, Inc. | 2 | $75 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,662 in reported general payments places this provider in the 80th percentile of 137 pain medicine providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 164 | $5,261 |
| Celecoxib | 57 | $2,718 |
| Gabapentin | 309 | $2,463 |
| Tizanidine Hcl | 167 | $943 |
| Pregabalin | 32 | $537 |
| Diclofenac Sodium | 31 | $404 |
| Nortriptyline Hcl | 28 | $360 |
| Amitriptyline Hcl | 14 | $287 |
| Doxepin Hcl | 20 | $234 |
| Cyclobenzaprine Hcl | 21 | $153 |
| Baclofen | 25 | $151 |
| Tramadol Hcl | 40 | $119 |
| Methylprednisolone | 16 | $117 |
| Topiramate | 21 | $42 |
| Oxycodone Hcl | 15 | $36 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in West Bridgewater
- Hariharan SundramNewton$1.7M
- Thomas SimopoulosBoston$181K
- Ivan UritsWareham$70K
- Antje BarreveldNewton$64K
- Arti OriBoston$62K
- Christine SangBoston$56K
- Ali EbrahimiBurlington$41K
- Alexandra AdlerLowell$35K
- Eduard VaynbergBoston$32K
- David GarasNatick$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.